Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fondazione del Piemonte per l'Oncologia
Mayo Clinic
STORM Therapeutics LTD
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Children's Oncology Group
AstraZeneca
Radiopharm Theranostics, Ltd
Arvinas Inc.
Immatics US, Inc.
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
Essen Biotech
Genentech, Inc.
St. Jude Children's Research Hospital
DualityBio Inc.
MacroGenics
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
University of Nebraska
National Institutes of Health Clinical Center (CC)
Elephas
Innate Pharma
Elephas
OncoNano Medicine, Inc.
Mayo Clinic
GV20 Therapeutics
Cancer Research UK
West China Hospital
DualityBio Inc.
University of Pittsburgh
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Arizona
Hadassah Medical Organization
Travera Inc
Guardant Health, Inc.
Institut Claudius Regaud
Marengo Therapeutics, Inc.
UNICANCER
Stanford University
University Health Network, Toronto
Vall d'Hebron Institute of Oncology